Original Research
Published on 22 Jul 2021
Serum Adropin as a Potential Biomarker for Predicting the Development of Type 2 Diabetes Mellitus in Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease
in Clinical and Translational Physiology
- 6,092 views
- 21 citations